Oura Ring 5 – What’s New Beyond the Smaller Design
The new signal architecture of Oura Ring 5 allows users to experience more accurate activity detection than any previous generation.
The new signal architecture of Oura Ring 5 allows users to experience more accurate activity detection than any previous generation.
The RELIEV-CM2 trial will evaluate the safety and efficacy of the ShiraTronics system, a fully implantable neurostimulator, in adults with chronic migraine.
Doctors discuss how QR678 PREO, developed using the principles of Precision Re-engineered Efficacy Optimization (PREO), may help improve consistency and reduce variability in hair restoration outcomes.
The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the stringent requirements of the European Pharmacopoeia.
The company says its new genomic newborn screening service analyzes 595 carefully selected genes associated with childhood-onset conditions where early intervention may improve outcomes.
SKIA plans to enter the US market through a strategic partnership with hardware provider Structure.
With the FDA approval, Haisco’s Cipepofol becomes the first China-originated innovative intravenous anesthetic to enter the global market.
India’s healthcare, pharmaceutical, and medical device industries are set for another dynamic year in 2026, with several major conferences, expos, and summits taking place across the country.
The revised sampling guidelines mandate that every Drugs Inspector collect at least 10 samples per month.
If approved, Zydus Therapeutics plans to launch saroglitazar in the United States in Q4 of FY 27.